侵襲性真菌感染症 (IFI) は、人体の深部組織、臓器、または血流に侵入した真菌によって引き起こされる重篤で生命を脅かす可能性がある感染症です。これらの感染症は、化学療法や臓器移植を受けている人など、免疫系が低下している人、または糖尿病や HIV/AIDS などの特定の病状を持つ人に発生する可能性があります。真菌には数十万種があり、そのうち約 100 種が人間に感染する可能性がありますが、致死的なものは限定的です。Journal of Fungi (JOF) のまとめによると、真菌感染症の変異種が確認されている場合、その罹患数は世界中で 10 億人を超えています。これらは、感染者にとって多かれ少なかれ重症となるさまざまな真菌株に分布しています。最も重篤な感染症の総称は、侵襲性（全身性）感染症です。最も一般的な侵入性真菌感染症は、カンジダ症、アスペルギルス症、クリプトコッカス症です。世界の浸潤性真菌感染症市場は、2022 年に 71 億 3,000 万ドルと評価され、2028 年には 90 億ドルになると予想されます。
目次
Table of Contents
1. Executive Summary
2. Introduction
2.1 Invasive Fungal Infections: An Overview
2.1.1 Definition of Invasive Fungal Infections
2.2 Invasive Fungal Infections Segmentation: An Overview
2.2.1 Invasive Fungal Infections Segmentation
3. Global Market Analysis
3.1 Global Invasive Fungal Infections Market: An Analysis
3.1.1 Global Invasive Fungal Infections Market: An Overview
3.1.2 Global Invasive Fungal Infections Market by Value
3.1.3 Global Invasive Fungal Infections Market by Molecule Class (Azoles, Echinocandins, Allylamines/Pyrimidines, Polyenes and Others)
3.1.4 Global Invasive Fungal Infections Market by Infection Type (Candidiasis, Aspergillosis, Cryptococcus, and Other)
3.1.5 Global Invasive Fungal Infections Market by Region (North America, Europe, Asia Pacific and Rest of the World)
3.2 Global Invasive Fungal Infections Market: Molecule Class Analysis
3.2.1 Global Invasive Fungal Infections Market by Molecule Class: An Overview
3.2.2 Global Azoles Invasive Fungal Infections Market by Value
3.2.3 Global Echinocandins Invasive Fungal Infections Market by Value
3.2.4 Global Allylamines/Pyrimidines Invasive Fungal Infections Market by Value
3.2.5 Global Polyenes Invasive Fungal Infections Market by Value
3.2.6 Global Other Invasive Fungal Infections Molecule Class Market by Value
3.3 Global Invasive Fungal Infections Market: Infection Type Analysis
3.3.1 Global Invasive Fungal Infections Market by Infection Type: An Overview
3.3.2 Global Invasive Candidiasis Fungal Infections Market by Value
3.3.3 Global Invasive Aspergillosis Fungal Infections Market by Value
3.3.4 Global Invasive Cryptococcus Fungal Infections Market by Value
3.3.5 Global Other Invasive Fungal Infections Market by Value
4. Regional Market Analysis
4.1 North America Invasive Fungal Infections Market: An Analysis
4.1.1 North America Invasive Fungal Infections Market: An Overview
4.1.2 North America Invasive Fungal Infections Market by Value
4.1.3 North America Invasive Fungal Infections Market by Region (The US, Canada, and Mexico)
4.1.4 The US Invasive Fungal Infections Market by Value
4.1.5 Canada Invasive Fungal Infections Market by Value
4.1.6 Mexico Invasive Fungal Infections Market by Value
4.2 Europe Invasive Fungal Infections Market: An Analysis
4.2.1 Europe Invasive Fungal Infections Market: An Overview
4.2.2 Europe Invasive Fungal Infections Market by Value
4.2.3 Europe Invasive Fungal Infections Market by Region (Germany, UK, France, Italy, Spain, and Rest of Europe)
4.2.4 Germany Invasive Fungal Infections Market by Value
4.2.5 United Kingdom Invasive Fungal Infections Market by Value
4.2.6 France Invasive Fungal Infections Market by Value
4.2.7 Italy Invasive Fungal Infections Market by Value
4.2.8 Spain Invasive Fungal Infections Market by Value
4.2.9 Rest of Europe Invasive Fungal Infections Market by Value
4.3 Asia Pacific Invasive Fungal Infections Market: An Analysis
4.3.1 Asia Pacific Invasive Fungal Infections Market: An Overview
4.3.2 Asia Pacific Invasive Fungal Infections Market by Value
4.3.3 Asia Pacific Invasive Fungal Infections Market by Region (China, Japan, India, and Rest of the Asia Pacific)
4.3.4 China Invasive Fungal Infections Market by Value
4.3.5 Japan Invasive Fungal Infections Market by Value
4.3.6 India Invasive Fungal Infections Market by Value
4.3.7 Rest of Asia Pacific Invasive Fungal Infections Market by Value
4.4 Rest of the World Invasive Fungal Infections Market: An Analysis
4.4.1 Rest of the World Invasive Fungal Infections Market: An Overview
4.4.2 Rest of the World Invasive Fungal Infections Market by Value
5. Impact of COVID-19
5.1. Impact of COVID-19 on Invasive Fungal Infections Market
5.2 Post COVID Scenario
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Increasing Invasive Fungal Infections with Life-threatening Conditions
6.1.2 Rapid Urbanization
6.1.3 Aging Population
6.1.4 Increasing Healthcare Expenditure
6.1.5 Increasing Government Support
6.1.6 Advancements in Antifungal Drug Development
6.1.7 Changing Lifestyles and Environmental Factor
6.2 Challenges
6.2.1 High Adverse Effects and Usage of Conventional Drugs
6.2.2 Complex and Evolving Fungal Pathogens
6.3 Market Trends
6.3.1 Use of AI in Vaccine and Drug Design
6.3.2 Increase in R&D Activities
6.3.3 Advancements in Diagnostic Techniques
6.3.4 Increase in Usage of Nanotechnology in Formulation of Advanced Antifungal Drugs
7. Competitive Landscape
7.1 Global Invasive Fungal Infections Players by Market Share
7.2 Global Invasive Fungal Infections Market Players: Key Comparison
7.3 Global Invasive Fungal Infections Market Players: Products Pipeline
8. Company Profiles
8.1 GlaxoSmithKline Plc
8.1.1 Business Overview
8.1.2 Sales by Products
8.1.3 Business Strategies
8.2 Merck & Co., Inc.
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategies
8.3 Pfizer Inc.
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategies
8.4 Cidara Therapeutics, Inc.
8.4.1 Business Overview
8.4.2 Revenue from Collaboration and License Agreement
8.4.3 Business Strategies
8.5 Astellas Pharma Inc.
8.5.1 Business Overview
8.5.2 Sales by Region
8.5.3 Business Strategy
8.6 Gilead Sciences, Inc.
8.6.1 Business Overview
8.6.2 Sales by Product
8.6.3 Business Strategies
8.7 Novo Nordisk A/S (Xellia Pharmaceuticals)
8.7.1 Business Overview
8.7.2 Operating Segments
8.7.3 Business Strategy
8.8 Biosergen AB
8.8.1 Business Overview
8.8.2 Business Strategies
8.9 Matinas BioPharma Holdings, Inc.
8.9.1 Business Overview
8.9.2 Business Strategies
8.10 Pulmocide Ltd.
8.10.1 Business Overview
8.10.2 Business Strategies
8.11 F2G Ltd.
8.11.1 Business Overview
8.11.2 Business Strategies
List of Figures
Figure 1: Common Types of Invasive Fungal Infections
Figure 2: Invasive Fungal Infections Segmentation
Figure 3: Global Invasive Fungal Infections Market by Value; 2018-2022 (US$ Billion)
Figure 4: Global Invasive Fungal Infections Market by Value; 2023-2028 (US$ Billion)
Figure 5: Global Invasive Fungal Infections Market by Molecule Class; 2022 (Percentage, %)
Figure 6: Global Invasive Fungal Infections Market by Infection Type; 2022 (Percentage, %)
Figure 7: Global Invasive Fungal Infections Market by Region; 2022 (Percentage, %)
Figure 8: Global Azoles Invasive Fungal Infections Market by Value; 2018-2022 (US$ Billion)
Figure 9: Global Azoles Invasive Fungal Infections Market by Value; 2023-2028 (US$ Billion)
Figure 10: Global Echinocandins Invasive Fungal Infections Market by Value; 2018-2022 (US$ Billion)
Figure 11: Global Echinocandins Invasive Fungal Infections Market by Value; 2023-2028 (US$ Billion)
Figure 12: Global Allylamines/Pyrimidines Invasive Fungal Infections Market by Value; 2018-2022 (US$ Million)
Figure 13: Global Allylamines/Pyrimidines Invasive Fungal Infections Market by Value; 2023-2028 (US$ Billion)
Figure 14: Global Polyenes Invasive Fungal Infections Market by Value; 2018-2022 (US$ Million)
Figure 15: Global Polyenes Invasive Fungal Infections Market by Value; 2023-2028 (US$ Billion)
Figure 16: Global Other Invasive Fungal Infections Molecule Class Market by Value; 2018-2022 (US$ Million)
Figure 17: Global Other Invasive Fungal Infections Molecule Class Market by Value; 2023-2028 (US$ Million)
Figure 18: Global Invasive Candidiasis Fungal Infections Market by Value; 2018-2022 (US$ Billion)
Figure 19: Global Invasive Candidiasis Fungal Infections Market by Value; 2023-2028 (US$ Billion)
Figure 20: Global Invasive Aspergillosis Fungal Infections Market by Value; 2018-2022 (US$ Billion)
Figure 21: Global Invasive Aspergillosis Fungal Infections Market by Value; 2023-2028 (US$ Billion)
Figure 22: Global Invasive Cryptococcus Fungal Infections Market by Value; 2018-2022 (US$ Million)
Figure 23: Global Invasive Cryptococcus Fungal Infections Market by Value; 2023-2028 (US$ Million)
Figure 24: Global Other Invasive Fungal Infections Market by Value; 2018-2022 (US$ Billion)
Figure 25: Global Other Invasive Fungal Infections Market by Value; 2023-2028 (US$ Billion)
Figure 26: North America Invasive Fungal Infections Market by Value; 2018-2022 (US$ Billion)
Figure 27: North America Invasive Fungal Infections Market by Value; 2023-2028 (US$ Billion)
Figure 28: North America Invasive Fungal Infections Market by Region; 2022 (Percentage, %)
Figure 29: The US Invasive Fungal Infections Market by Value; 2018-2022 (US$ Billion)
Figure 30: The US Invasive Fungal Infections Market by Value; 2023-2028 (US$ Billion)
Figure 31: Canada Invasive Fungal Infections Market by Value; 2018-2022 (US$ Million)
Figure 32: Canada Invasive Fungal Infections Market by Value; 2023-2028 (US$ Million)
Figure 33: Mexico Invasive Fungal Infections Market by Value; 2018-2022 (US$ Million)
Figure 34: Mexico Invasive Fungal Infections Market by Value; 2023-2028 (US$ Million)
Figure 35: Europe Invasive Fungal Infections Market by Value; 2018-2022 (US$ Billion)
Figure 36: Europe Invasive Fungal Infections Market by Value; 2023-2028 (US$ Billion)
Figure 37: Europe Invasive Fungal Infections Market by Region; 2022 (Percentage, %)
Figure 38: Germany Invasive Fungal Infections Market by Value; 2018-2022 (US$ Million)
Figure 39: Germany Invasive Fungal Infections Market by Value; 2023-2028 (US$ Million)
Figure 40: United Kingdom Invasive Fungal Infections Market by Value; 2018-2022 (US$ Million)
Figure 41: United Kingdom Invasive Fungal Infections Market by Value; 2023-2028 (US$ Million)
Figure 42: France Invasive Fungal Infections Market by Value; 2018-2022 (US$ Million)
Figure 43: France Invasive Fungal Infections Market by Value; 2023-2028 (US$ Million)
Figure 44: Italy Invasive Fungal Infections Market by Value; 2018-2022 (US$ Million)
Figure 45: Italy Invasive Fungal Infections Market by Value; 2023-2028 (US$ Million)
Figure 46: Spain Invasive Fungal Infections Market by Value; 2018-2022 (US$ Million)
Figure 47: Spain Invasive Fungal Infections Market by Value; 2023-2028 (US$ Million)
Figure 48: Rest of Europe Invasive Fungal Infections Market by Value; 2018-2022 (US$ Million)
Figure 49: Rest of Europe Invasive Fungal Infections Market by Value; 2023-2028 (US$ Million)
Figure 50: Asia Pacific Invasive Fungal Infections Market by Value; 2018-2022 (US$ Billion)
Figure 51: Asia Pacific Invasive Fungal Infections Market by Value; 2023-2028 (US$ Billion)
Figure 52: Asia Pacific Invasive Fungal Infections Market by Region; 2022 (Percentage, %)
Figure 53: China Invasive Fungal Infections Market by Value, 2018-2022 (US$ Million)
Figure 54: China Invasive Fungal Infections Market by Value; 2023-2028 (US$ Million)
Figure 55: Japan Invasive Fungal Infections Market by Value, 2018-2022 (US$ Million)
Figure 56: Japan Invasive Fungal Infections Market by Value; 2023-2028 (US$ Million)
Figure 57: India Invasive Fungal Infections Market by Value, 2018-2022 (US$ Million)
Figure 58: India Invasive Fungal Infections Market by Value; 2023-2028 (US$ Million)
Figure 59: Rest of Asia Pacific Invasive Fungal Infections Market by Value, 2018-2022 (US$ Million)
Figure 60: Rest of Asia Pacific Invasive Fungal Infections Market by Value; 2023-2028 (US$ Million)
Figure 61: Rest of the World Invasive Fungal Infections Market by Value; 2018-2022 (US$ Million)
Figure 62: Rest of the World Invasive Fungal Infections Market by Value; 2023-2028 (US$ Million)
Figure 63: Expected Prevalence of Invasive Fungal Infections in The US, European Union, UK, Japan & India, 2034 (Thousand)
Figure 64: Global Urban Population as a Share of Total Population; 2016, 2021 & 2050 (Percentage, %)
Figure 65: Global Percentage Of Population Aged 65 Years Or Over; 2022, 2030 & 2050 (Percentage, %)
Figure 66: The US Health Consumption Expenditure as a Percentage of GDP; 2016-2022 (Percentage, %)
Figure 67: Global Market Size for Artificial Intelligence in Healthcare; 2021-2030 (US$ Billion)
Figure 68: Global Invasive Fungal Infections Players by Market Share; 2022 (Percentage, %)
Figure 69: GlaxoSmithKline Plc Sales by Products; 2022 (Percentage, )
Figure 70: Merck & Co., Inc. Sales by Segments; 2022 (Percentage, %)
Figure 71: Pfizer Inc. Revenue by Segment; 2022 (Percentage,%)
Figure 72: Cidara Therapeutics, Inc. Revenue from Collaboration and License Agreements; 2022 (Percentage, %)
Figure 73: Astellas Pharma Inc. Sales by Region; 2022 (Percentage, %)
Figure 74: Gilead Sciences, Inc. Sales by Product; 2022 (Percentage, %)
Figure 75: Novo Nordisk A/S Net Sales by Segment; 2022 (Percentage, %)
Table 1: Global Invasive Fungal Infections Market Players: Key Comparison
Table 2: Global Invasive Fungal Infections Market Players: Products Pipeline
